País: Alemanha
Língua: alemão
Origem: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Antigene des Influenza-Virus A/Moscow/10/99 (H3N2), Stamm A/Panama/2007/99 Resvir-17, Antigene des Influenza-Virus A/New Caledonia/20/99 (H1N1), Stamm A/New Caledonia/20/99 IVR-116, Antigene des Influenza-Virus B/Hong Kong/330/2001, Stamm B/Shangdong/7/97
Seqirus Vaccines Limited (BS 1)
Antigens of the Influenza Virus A/Moscow/10/99 (H3N2), strain A/Panama/2007/99 Resvir-17, antigens of Influenza Virus A/New Caledonia/20/99 (H1N1), strain A/New Caledonia/20/99 IVR-116, antigens of Influenza Virus B/Hong Kong/330/2001 strain B/Shangdong/7/97
Suspension zur Injektion
Antigene des Influenza-Virus A/Moscow/10/99 (H3N2), Stamm A/Panama/2007/99 Resvir-17 15.µgHA; Antigene des Influenza-Virus A/New Caledonia/20/99 (H1N1), Stamm A/New Caledonia/20/99 IVR-116 15.µgHA; Antigene des Influenza-Virus B/Hong Kong/330/2001, Stamm B/Shangdong/7/97 15.µgHA
gültig